BILIFALK
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 May 2017)
What this means for you
This application is over — abandoned 08 May 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86025219
- Mark type
- Stylized text
- Filed
- 31 Jul 2013
- Published for opposition
- 04 Feb 2014
- Abandoned
- 08 May 2017
- Attorney of record
- David G. Boutell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the dissolution of cholesterol gallstones in the gallbladder, for the treatment of biliary reflux gastritis, of cholestatic liver diseases and of cystic fibrosis associated liver disease
Owner
- Dr. Falk Pharma GmbH, Freiburg, DE
- Dr. Falk Pharma GmbH, Freiburg, DE
Prosecution history
- 08 May 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 08 May 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Aug 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Aug 2016 — SOU EXTENSION 5 GRANTED
- 17 Aug 2016 — SOU EXTENSION 5 FILED
- 17 Aug 2016 — SOU TEAS EXTENSION RECEIVED
- 02 Mar 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2016 — SOU EXTENSION 4 GRANTED
- 18 Feb 2016 — SOU EXTENSION 4 FILED
- 18 Feb 2016 — SOU TEAS EXTENSION RECEIVED
- 18 Aug 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2015 — SOU EXTENSION 3 GRANTED
- 05 Aug 2015 — SOU EXTENSION 3 FILED
- 05 Aug 2015 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED